- Home
- HNI vs MRUS Comparison
HNI vs MRUS Comparison
Compare HNI & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HNI
- MRUS
- Stock Information
- Founded
- HNI 1944
- MRUS 2003
- Country
- HNI United States
- MRUS Netherlands
- Employees
- HNI N/A
- MRUS N/A
- Industry
- HNI Office Equipment/Supplies/Services
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- HNI Consumer Discretionary
- MRUS Health Care
- Exchange
- HNI Nasdaq
- MRUS Nasdaq
- Market Cap
- HNI 2.4B
- MRUS 2.9B
- IPO Year
- HNI N/A
- MRUS 2016
- Fundamental
- Price
- HNI $51.26
- MRUS $39.74
- Analyst Decision
- HNI Strong Buy
- MRUS Strong Buy
- Analyst Count
- HNI 1
- MRUS 12
- Target Price
- HNI $63.00
- MRUS $87.92
- AVG Volume (30 Days)
- HNI 429.1K
- MRUS 658.9K
- Earning Date
- HNI 02-20-2025
- MRUS 02-26-2025
- Dividend Yield
- HNI 2.55%
- MRUS N/A
- EPS Growth
- HNI 159.58
- MRUS N/A
- EPS
- HNI 2.56
- MRUS N/A
- Revenue
- HNI $2,563,700,000.00
- MRUS $35,932,000.00
- Revenue This Year
- HNI $5.42
- MRUS N/A
- Revenue Next Year
- HNI $2.73
- MRUS $57.49
- P/E Ratio
- HNI $20.02
- MRUS N/A
- Revenue Growth
- HNI 10.36
- MRUS N/A
- 52 Week Low
- HNI $40.22
- MRUS $33.60
- 52 Week High
- HNI $58.42
- MRUS $61.61
- Technical
- Relative Strength Index (RSI)
- HNI 52.82
- MRUS 39.51
- Support Level
- HNI $45.83
- MRUS $38.52
- Resistance Level
- HNI $51.24
- MRUS $47.75
- Average True Range (ATR)
- HNI 1.10
- MRUS 2.02
- MACD
- HNI 0.44
- MRUS -0.14
- Stochastic Oscillator
- HNI 92.81
- MRUS 19.74
About HNI HNI Corporation
HNI Corp is a provider of office furniture and hearth products. The company generates the bulk of its revenue from its workplace furnishing, which consists of panel-based and freestanding furniture systems, seating, storage, tables, and architectural products. These products are sold through a national system of dealers, wholesalers, and office product distributors but also directly to end-user customers and federal, state, and local governments. Residential building products include a full array of gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, and accessories. The company has operations in the United States, Canada, Mainland China, Hong Kong, India, Mexico, and Taiwan.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.